Effects of insulin therapy on weight gain and fat distribution in the HF/HS-STZ rat model of type 2 diabetes

Modeling type 2 diabetes in rats using high fat diet and streptozotocin

(2014) Søs Skovsø   Journal of Diabetes Investigation

Determinants of Weight Gain in the Action to Control Cardiovascular Risk in Diabetes Trial

(2013) V. Fonseca et al.   DIABETES CARE

Standards of Medical Care in Diabetes--2014

(2013)   DIABETES CARE

Acute reduction of lipolysis reduces adiponectin and IL-18: evidence from an intervention study with acipimox and insulin

(2013) B. Lindegaard et al.   DIABETOLOGIA

The Effect of Early Intensive Insulin Therapy on Body Fat Distribution andβ-Cell Function in Newly Diagnosed Type 2 Diabetes

(2013) Jang Won Son et al.   ENDOCRINE RESEARCH

Hyperinsulinemia Drives Diet-Induced Obesity Independently of Brain Insulin Production

(2012) Arya E. Mehran et al.   Cell Metabolism

Glycemic Control Over 5 Years in 4,900 People With Type 2 Diabetes: Real-world diabetes therapy in a clinical trial cohort

(2012) J. D. Best et al.   DIABETES CARE

The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk

(2012) B. M. Kaess et al.   DIABETOLOGIA

Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease

(2012) Anette Varbo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Increase of body weight during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysis

(2011) A. E. Pontiroli et al.   DIABETES OBESITY & METABOLISM

Effects of intensive insulin therapy alone and in combination with pioglitazone on body weight, composition, distribution and liver fat content in patients with type 2 diabetes

(2011) P. K. Shah et al.   DIABETES OBESITY & METABOLISM

Changes in serum adiponectin concentrations and endothelial function after intensive insulin treatment in people with newly diagnosed type 2 diabetes: A pilot study

(2011) Fang Li et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Abdominal adiposity depots are correlates of adverse cardiometabolic risk factors in Caucasian and African-American adults

(2011) R L Newton et al.   Nutrition & Diabetes

Analytical performance evaluation of a particle-enhanced turbidimetric cystatin C assay on the Roche COBAS 6000 analyzer

(2010) Manuel Conde-Sánchez et al.   CLINICAL BIOCHEMISTRY

Pharmacological Vasodilation Improves Insulin-Stimulated Muscle Protein Anabolism but Not Glucose Utilization in Older Adults

(2010) K. L. Timmerman et al.   DIABETES

Gluteofemoral body fat as a determinant of metabolic health

(2010) K N Manolopoulos et al.   INTERNATIONAL JOURNAL OF OBESITY

Mitochondrial respiration in subcutaneous and visceral adipose tissue from patients with morbid obesity

(2010) Regitze Kraunsøe et al.   JOURNAL OF PHYSIOLOGY-LONDON

Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial

(2010) Julio Rosenstock et al.   LANCET

Relation between visceral fat and coronary artery disease evaluated by multidetector computed tomography

(2009) Mateus D. Marques et al.   ATHEROSCLEROSIS

Prevention of Hepatic Steatosis and Hepatic Insulin Resistance by Knockdown of cAMP Response Element-Binding Protein

(2009) Derek M. Erion et al.   Cell Metabolism

Analytical performance evaluation of the Cobas 6000 analyzer – special emphasis on trueness verification

(2008) Adriaan J. van Gammeren et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Reduced Weight Gain with Insulin Detemir Compared to NPH Insulin Is Not Explained by a Reduction in Hypoglycemia

(2008) Melanie J. Davies et al.   Diabetes Technology & Therapeutics

Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients-The PREDICTIVE™ BMI clinical trial1

(2008) C. Fajardo Montañana et al.   DIABETIC MEDICINE